1477
Ocumension Therapeutics Ordinary Shares
APAC company
Healthcare
Biotechnology
/
NAV Price
-
Last Traded
-
Chg
-
-
XHKG
-
Updated: -
Times are shown in GMT+8, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.
SEHK:1477
KYG674111011
HKD
Loading Comparison
Latest 1477 News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News